177 related articles for article (PubMed ID: 30636580)
21. Overexpression of Evi-1 oncoprotein represses TGF-β signaling in colorectal cancer.
Deng X; Cao Y; Liu Y; Li F; Sambandam K; Rajaraman S; Perkins AS; Fields AP; Hellmich MR; Townsend CM; Thompson EA; Ko TC
Mol Carcinog; 2013 Apr; 52(4):255-264. PubMed ID: 22161860
[TBL] [Abstract][Full Text] [Related]
22. Exploring the Key Signaling Pathways and ncRNAs in Colorectal Cancer.
Lee YJ; Kim WR; Park EG; Lee DH; Kim JM; Shin HJ; Jeong HS; Roh HY; Kim HS
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674135
[TBL] [Abstract][Full Text] [Related]
23. The potential role of regulatory microRNAs of RAS/MAPK signaling pathway in the pathogenesis of colorectal cancer.
Soleimani A; Rahmani F; Saeedi N; Ghaffarian R; Khazaei M; Ferns GA; Avan A; Hassanian SM
J Cell Biochem; 2019 Dec; 120(12):19245-19253. PubMed ID: 31512778
[TBL] [Abstract][Full Text] [Related]
24. alpha2HS-glycoprotein, an antagonist of transforming growth factor beta in vivo, inhibits intestinal tumor progression.
Swallow CJ; Partridge EA; Macmillan JC; Tajirian T; DiGuglielmo GM; Hay K; Szweras M; Jahnen-Dechent W; Wrana JL; Redston M; Gallinger S; Dennis JW
Cancer Res; 2004 Sep; 64(18):6402-9. PubMed ID: 15374947
[TBL] [Abstract][Full Text] [Related]
25. Multispectral imaging reveals hyper active TGF-β signaling in colorectal cancer.
Yang L; Liu Z; Tan J; Dong H; Zhang X
Cancer Biol Ther; 2018 Feb; 19(2):105-112. PubMed ID: 29219668
[TBL] [Abstract][Full Text] [Related]
26. The TGFβ-signaling pathway and colorectal cancer: associations between dysregulated genes and miRNAs.
Pellatt AJ; Mullany LE; Herrick JS; Sakoda LC; Wolff RK; Samowitz WS; Slattery ML
J Transl Med; 2018 Jul; 16(1):191. PubMed ID: 29986714
[TBL] [Abstract][Full Text] [Related]
27. Loss of Smad signaling in human colorectal cancer is associated with advanced disease and poor prognosis.
Xie W; Rimm DL; Lin Y; Shih WJ; Reiss M
Cancer J; 2003; 9(4):302-12. PubMed ID: 12967141
[TBL] [Abstract][Full Text] [Related]
28. miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer.
Li J; Liang H; Bai M; Ning T; Wang C; Fan Q; Wang Y; Fu Z; Wang N; Liu R; Zen K; Zhang CY; Chen X; Ba Y
PLoS One; 2015; 10(6):e0130194. PubMed ID: 26061281
[TBL] [Abstract][Full Text] [Related]
29. Colorectal cancer cell-derived exosomes containing miR-10b regulate fibroblast cells via the PI3K/Akt pathway.
Dai G; Yao X; Zhang Y; Gu J; Geng Y; Xue F; Zhang J
Bull Cancer; 2018 Apr; 105(4):336-349. PubMed ID: 29496262
[TBL] [Abstract][Full Text] [Related]
30. Mice with dysfunctional TGF-β signaling develop altered intestinal microbiome and colorectal cancer resistant to 5FU.
Wang Z; Hopson LM; Singleton SS; Yang X; Jogunoori W; Mazumder R; Obias V; Lin P; Nguyen BN; Yao M; Miller L; White J; Rao S; Mishra L
Biochim Biophys Acta Mol Basis Dis; 2021 Oct; 1867(10):166179. PubMed ID: 34082069
[TBL] [Abstract][Full Text] [Related]
31. Masking epistasis between MYC and TGF-β pathways in antiangiogenesis-mediated colon cancer suppression.
Dews M; Tan GS; Hultine S; Raman P; Choi J; Duperret EK; Lawler J; Bass A; Thomas-Tikhonenko A
J Natl Cancer Inst; 2014 Apr; 106(4):dju043. PubMed ID: 24627270
[TBL] [Abstract][Full Text] [Related]
32. Role of TGF-β signaling regulatory microRNAs in the pathogenesis of colorectal cancer.
Soleimani A; Khazaei M; Ferns GA; Ryzhikov M; Avan A; Hassanian SM
J Cell Physiol; 2019 Sep; 234(9):14574-14580. PubMed ID: 30684274
[TBL] [Abstract][Full Text] [Related]
33. Transforming growth factor-beta pathway disruption and infiltration of colorectal cancers by intraepithelial lymphocytes.
Baker K; Chong G; Foulkes WD; Jass JR
Histopathology; 2006 Oct; 49(4):371-80. PubMed ID: 16978200
[TBL] [Abstract][Full Text] [Related]
34. Role of Regulatory Oncogenic or Tumor Suppressor miRNAs of PI3K/AKT Signaling Axis in the Pathogenesis of Colorectal Cancer.
Soleimani A; Rahmani F; Ferns GA; Ryzhikov M; Avan A; Hassanian SM
Curr Pharm Des; 2018; 24(39):4605-4610. PubMed ID: 30636581
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGFβR1.
Xu X; Chen R; Li Z; Huang N; Wu X; Li S; Li Y; Wu S
BMC Cancer; 2015 Dec; 15():1023. PubMed ID: 26714817
[TBL] [Abstract][Full Text] [Related]
36. Role of TGF-β in metastatic colon cancer: it is finally time for targeted therapy.
Villalba M; Evans SR; Vidal-Vanaclocha F; Calvo A
Cell Tissue Res; 2017 Oct; 370(1):29-39. PubMed ID: 28560691
[TBL] [Abstract][Full Text] [Related]
37. Crosstalk between TGF-β signaling and the microRNA machinery.
Butz H; Rácz K; Hunyady L; Patócs A
Trends Pharmacol Sci; 2012 Jul; 33(7):382-93. PubMed ID: 22613783
[TBL] [Abstract][Full Text] [Related]
38. Colorectal carcinoma cell production of transforming growth factor beta decreases expression of endothelial cell vascular endothelial growth factor receptor 2.
Kuczynski EA; Viloria-Petit AM; Coomber BL
Cancer; 2011 Dec; 117(24):5601-11. PubMed ID: 21692070
[TBL] [Abstract][Full Text] [Related]
39. A Transition Zone Showing Highly Discontinuous or Alternating Levels of Stem Cell and Proliferation Markers Characterizes the Development of PTEN-Haploinsufficient Colorectal Cancer.
Arvai KJ; Hsu YH; Lee LA; Jones D
PLoS One; 2015; 10(6):e0131108. PubMed ID: 26098881
[TBL] [Abstract][Full Text] [Related]
40. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
